Evidence map›Paper›PMID 42840684›Full record

ReviewFrontiers in immunology2026

hnRNPs in immunity: from nucleic acid sensing to lymphocyte fate determination.

Daiquan Zhang, Jingwen Lei, Shaohui Tang, Shunyan Dong, Xuefei Lei, Lixing Yuan, Xinmei Cao

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daiquan Zhang *Department of Traditional Chinese Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Jingwen Lei *Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
Shaohui TangSchool of nursing, Southwest Medical University, Luzhou, China.
Shunyan DongSchool of nursing, Southwest Medical University, Luzhou, China.
Xuefei LeiSchool of nursing, Southwest Medical University, Luzhou, China.
Lixing YuanPublic Laboratory of West China Second University Hospital, Sichuan University, Chengdu, China.
Xinmei CaoImmune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous nuclear ribonucleoproteins (hnRNPs) constitute a family of RNA-binding proteins long recognized for their roles in pre-mRNA processing. However, accumulating evidence has established hnRNPs as central and versatile regulators of immunity. In innate immunity, some hnRNP family members recognize nucleic acids and metabolites to either promote or constrain inflammatory gene expression in a context-dependent manner. In adaptive immunity, they play essential roles in B cell activation and germinal center (GC) responses, as well as T cell activation, survival, and differentiation, primarily through the precise regulation of alternative splicing (AS). Here, we review the functions of hnRNPs (with a focus on A1, A2B1, I, K, L, M, and U) across innate and adaptive immunity, and discuss critical unresolved questions, including the often-overlooked axis of species-specific regulation.

Indexed as

Heterogeneous-Nuclear RibonucleoproteinsLymphocytesNucleic AcidsAdaptive ImmunityAlternative SplicingAnimalsB-LymphocytesCell DifferentiationHumansImmunity, InnateLymphocyte ActivationHeterogeneous-Nuclear RibonucleoproteinsNucleic Acidsadaptive immunityalternative splicinghnRNPinnate immunitymetabolite sensingnucleic acid sensingRNA-binding protein

Identifiers

PMID42840684
PMCPMC13640137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.